Founded in 2013, BioAscent is part of the BioCity group, and located within the BioCity Scotland site at Newhouse, Scotland.
Former Merck Sharpe and Dohme (MSD) Automated Compound Management and Logistics facility
BioAscent operates a former MSD Automated Compound Management and Logistics facility. Our team comprise the highly skilled management, scientists and technicians who commissioned and managed the facility since its establishment in 2005.
The compound storage facility was initially responsible for delivering compounds to the Organon screening sites at Newhouse and Oss (The Netherlands), in addition to varied research partners.
The facility was dramatically expanded after acquisition by Schering Plough, to become the global repository site for the company. The facility successfully supported all drug discovery operations in Europe, the US, and Asia.
Centre of Excellence for European Lead Factory
The Innovative Medicines Initiative (IMI) funded European Lead Factory (ELF) was launched on the 7th February 2013, with BioAscent selected as the “centre of excellence” for the Compound Management activities of the consortium, with responsibility for the collection, storage, distribution, HTS logistics (hit picking, support of follow-up studies) and inventory management of the Joint European Compound Collection.
We were able to recommission the facility and associated IT systems in order to deliver the compound management and logistics services for the European Lead Factory.